Bulacinski, Andrzej Benedykt et al. published their research in Acta Poloniae Pharmaceutica in 1989 | CAS: 25560-00-3

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. The piperidine ring can be found not only in more than half of the currently known structures of alkaloids, but also in many natural or synthetic compounds with interesting biological activities. The piperidine and polyhydroxylated indolizidine derivatives have shown to be promising 伪-glucosidase inhibitors. The former are analogs of DNJ with an improved 伪-glucosidase inhibitory profile than that of DNJ. Boisson et al.Product Details of 25560-00-3

Synthesis of acyclic and heterocyclic derivatives of 2-carboxyquinuclidine. V was written by Bulacinski, Andrzej Benedykt;Gutkowska, Bozenna. And the article was included in Acta Poloniae Pharmaceutica in 1989.Product Details of 25560-00-3 This article mentions the following:

Quinuclidine derivatives I [RR1N = PhCH2CHPhCH2NH, Ph2CHNH, 3-(2-methyl-1-piperidinyl)propylamino (II), 4-(2-hydroxyethyl)-1-piperazinyl (III), and 4-benzyl-1-piperazinyl (IV)] were prepared in 51-60% yields from 2-chlorocarbonylquinuclidine.HCl and the resp. RR1NH in C6H6 in the presence of Et3N. Reduction of II, III, and IV with LiAlH4 in Et2O-THF gave 65-72% the corresponding aminomethylquinuclidines V. In the experiment, the researchers used many compounds, for example, 3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3Product Details of 25560-00-3).

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. The piperidine ring can be found not only in more than half of the currently known structures of alkaloids, but also in many natural or synthetic compounds with interesting biological activities. The piperidine and polyhydroxylated indolizidine derivatives have shown to be promising 伪-glucosidase inhibitors. The former are analogs of DNJ with an improved 伪-glucosidase inhibitory profile than that of DNJ. Boisson et al.Product Details of 25560-00-3

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Wijtmans, Maikel et al. published their research in European Journal of Medicinal Chemistry in 2012 | CAS: 25560-00-3

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. Piperidine and its derivatives have become increasingly popular in many synthetic schemes. Piperidine derivatives bearing a masked aldehyde function in the 蔚-position are easily transformed into quinolizidine compounds through intramolecular reductive amination.Application of 25560-00-3

Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists was written by Wijtmans, Maikel;Maussang, David;Sirci, Francesco;Scholten, Danny J.;Canals, Meritxell;Mujic-Delic, Azra;Chong, Milagros;Chatalic, Kristell L. S.;Custers, Hans;Janssen, Elwin;de Graaf, Chris;Smit, Martine J.;de Esch, Iwan J. P.;Leurs, Rob. And the article was included in European Journal of Medicinal Chemistry in 2012.Application of 25560-00-3 This article mentions the following:

The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the 尾-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacol. and the therapeutic potential of CXCR7. In the present study, 24 derivatives were synthesized based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pKi values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds I and II (VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of 尾-arrestin 2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research. In the experiment, the researchers used many compounds, for example, 3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3Application of 25560-00-3).

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. Piperidine and its derivatives have become increasingly popular in many synthetic schemes. Piperidine derivatives bearing a masked aldehyde function in the 蔚-position are easily transformed into quinolizidine compounds through intramolecular reductive amination.Application of 25560-00-3

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Bulacinski, Andrzej Benedykt et al. published their research in Acta Poloniae Pharmaceutica in 1989 | CAS: 25560-00-3

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. The piperidine ring can be found not only in more than half of the currently known structures of alkaloids, but also in many natural or synthetic compounds with interesting biological activities. The piperidine and polyhydroxylated indolizidine derivatives have shown to be promising α-glucosidase inhibitors. The former are analogs of DNJ with an improved α-glucosidase inhibitory profile than that of DNJ. Boisson et al.Product Details of 25560-00-3

Synthesis of acyclic and heterocyclic derivatives of 2-carboxyquinuclidine. V was written by Bulacinski, Andrzej Benedykt;Gutkowska, Bozenna. And the article was included in Acta Poloniae Pharmaceutica in 1989.Product Details of 25560-00-3 This article mentions the following:

Quinuclidine derivatives I [RR1N = PhCH2CHPhCH2NH, Ph2CHNH, 3-(2-methyl-1-piperidinyl)propylamino (II), 4-(2-hydroxyethyl)-1-piperazinyl (III), and 4-benzyl-1-piperazinyl (IV)] were prepared in 51-60% yields from 2-chlorocarbonylquinuclidine.HCl and the resp. RR1NH in C6H6 in the presence of Et3N. Reduction of II, III, and IV with LiAlH4 in Et2O-THF gave 65-72% the corresponding aminomethylquinuclidines V. In the experiment, the researchers used many compounds, for example, 3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3Product Details of 25560-00-3).

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. The piperidine ring can be found not only in more than half of the currently known structures of alkaloids, but also in many natural or synthetic compounds with interesting biological activities. The piperidine and polyhydroxylated indolizidine derivatives have shown to be promising α-glucosidase inhibitors. The former are analogs of DNJ with an improved α-glucosidase inhibitory profile than that of DNJ. Boisson et al.Product Details of 25560-00-3

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem

 

Wijtmans, Maikel et al. published their research in European Journal of Medicinal Chemistry in 2012 | CAS: 25560-00-3

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. Piperidine and its derivatives have become increasingly popular in many synthetic schemes. Piperidine derivatives bearing a masked aldehyde function in the ε-position are easily transformed into quinolizidine compounds through intramolecular reductive amination.Application of 25560-00-3

Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists was written by Wijtmans, Maikel;Maussang, David;Sirci, Francesco;Scholten, Danny J.;Canals, Meritxell;Mujic-Delic, Azra;Chong, Milagros;Chatalic, Kristell L. S.;Custers, Hans;Janssen, Elwin;de Graaf, Chris;Smit, Martine J.;de Esch, Iwan J. P.;Leurs, Rob. And the article was included in European Journal of Medicinal Chemistry in 2012.Application of 25560-00-3 This article mentions the following:

The chemokine receptor CXCR7 is an atypical G protein-coupled receptor as it preferentially signals through the β-arrestin pathway rather than through G proteins. CXCR7 is thought to be of importance in cancer and the development of CXCR7-targeting ligands is of huge importance to further elucidate the pharmacol. and the therapeutic potential of CXCR7. In the present study, 24 derivatives were synthesized based on a compound scaffold patented by Chemocentryx and obtained CXCR7 ligands with pKi values ranging from 5.3 to 8.1. SAR studies were supported by computational 3D Fingerprint studies, revealing several important affinity descriptors. Two key compounds I and II (VUF11207 and VUF11403) were found to be high-potency ligands that induce recruitment of β-arrestin 2 and subsequent internalization of CXCR7, making them important tool compounds in future CXCR7 research. In the experiment, the researchers used many compounds, for example, 3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3Application of 25560-00-3).

3-(2-Methylpiperidin-1-yl)propan-1-amine (cas: 25560-00-3) belongs to piperidine derivatives. Piperidine and its derivatives have become increasingly popular in many synthetic schemes. Piperidine derivatives bearing a masked aldehyde function in the ε-position are easily transformed into quinolizidine compounds through intramolecular reductive amination.Application of 25560-00-3

Referemce:
Piperidine – Wikipedia,
Piperidine | C5H11N – PubChem